Roberttanser
436 posts
May 30, 2026
3:00 AM
|
Megalis 10 mg is mentioned in product documents and in broader scientific tadalafil literature, but the exact brand name is rarely the focus of journal articles. The most relevant scientific articles are usually about tadalafil 10 mg, the active ingredient in Megalis, rather than the brand itself.
Scientific mentions
One clinical study in The Journal of Sexual Medicine compared tadalafil 10 mg and 20 mg in Japanese men with severe erectile dysfunction, finding that both doses were effective and well tolerated, with stronger results in some patients at 20 mg. Another long-term safety study in European Urology reported that tadalafil at 5 mg, 10 mg, and 20 mg was safe and well tolerated over 18 to 24 months in erectile dysfunction management.
Product and monograph sources
Brand-specific documents for MEGALIS 10 MG describe it as a tadalafil tablet used for erectile dysfunction, benign prostatic hyperplasia, and sometimes pulmonary arterial hypertension. A summary reference on tadalafil also confirms its approved clinical uses for ED, BPH, and PAH, which is the scientific basis behind Megalis 10 mg.
What this means
So, if you are looking for scientific articles that “mention Megalis 10 mg,” the answer is that most peer-reviewed papers will mention tadalafil 10 mg instead of the brand name Megalis. Brand-name references are more commonly found in product information sheets and regulatory documents than in academic journals.
A practical search strategy is to look for papers on “tadalafil 10 mg,” “ED tadalafil dose comparison,” or “long-term tadalafil safety,” since those are the studies most directly relevant to Megalis 10 mg.
|
